INTERNATIONAL PATENT: IMMUNOCORE LIMITED FILES APPLICATION FOR "METHOD OF TREATING CANCER USING A GENE EXPRESSION SIGNATURE"

GENEVA, Nov. 3 -- IMMUNOCORE LIMITED (92 Park Drive, Milton ParkAbingdon, Oxon OX14 4RY) filed a patent application (PCT/IB2025/054329) for "METHOD OF TREATING CANCER USING A GENE EXPRESSION SIGNATURE" on Apr 25, 2025. With publication no. WO/2025/224692, the details related to the patent application was published on Oct 30, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): KIRK, Peter (c/o Immunocore Limited92 Park Drive, Milton ParkAbingdon, Oxon OX14 4RY), COLLINS, Laura (c/o Immunocore Limited92 Park Drive, Milton ParkAbingdon, Oxon OX14 4RY), GREENSHIELDS-WATSON, Alexander (c/o Immunocore...